1388842-44-1 Usage
General Description
(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid, also known as BPTAA, is a chemical compound with the molecular formula C14H7F12N3O2. It is a synthetic organic compound that belongs to the class of triazole fungicides. BPTAA is used to protect crops from fungal diseases by inhibiting the growth of fungi. (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid is known for its high efficacy and low environmental impact, making it a desirable alternative to traditional fungicides. Additionally, BPTAA has a high thermal stability, making it suitable for use in a wide range of agricultural applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1388842-44-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,8,8,4 and 2 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1388842-44:
(9*1)+(8*3)+(7*8)+(6*8)+(5*8)+(4*4)+(3*2)+(2*4)+(1*4)=211
211 % 10 = 1
So 1388842-44-1 is a valid CAS Registry Number.
1388842-44-1Relevant articles and documents
Preparation method of selinexor and intermediate thereof
-
Paragraph 0167-0170, (2021/04/21)
The invention relates to a preparation method of selinexor and an intermediate thereof, which has the advantages of short synthetic route, mild reaction conditions, no foul gas generation in the reaction process, high safety, wide acceptable range of vari
Acryloyl group-containing nuclear transport modulator and uses thereof
-
, (2020/09/12)
The invention relates to a novel acryloyl-containing compound as well as a preparation method and application thereof. Specifically, the invention relates to an acryloyl-containing compound as shown in a formula (1) and a preparation method thereof, and a
SOLID FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION
-
Page/Page column 60, (2017/08/01)
Aspects of the present application relate to solid forms of Selinexor, processes for their preparation and pharmaceutical compositions thereof. Specific aspects relate to crystalline and amorphous forms of Selinexor.